Takeda Pharmaceutical Co. Ltd.

In News

Takeda deepens AI drug discovery push with $1.7 billion Iambic deal - Reuters

Reuters - Feb 09, 2026

Takeda Pharmaceutical Co Ltd - U.S. FDA accepts NDA and grants Priority Review for Takeda's Oveporexton (TAK-861) as a potential first-in-class therapy for narcolepsy type 1 - marketscreener.com

marketscreener.com - Feb 10, 2026

Asia Deal Watch: Nxera Out-Licenses CPCR-Targeted Asset To Unnamed Start-Up - Citeline News & Insights

Citeline News & Insights - Feb 13, 2026

Takeda Taps AI Startup Iambic In $1.7 Billion+ Deal To Speed Up Drug Discovery - Benzinga

Benzinga - Feb 09, 2026

FDA grants Priority Review to Takeda (NYSE: TAK) narcolepsy type 1 therapy TAK-861 - Stock Titan

Stock Titan - Feb 10, 2026

Takeda Pharmaceutical Co. $TAK Shares Sold by Federated Hermes Inc. - MarketBeat

MarketBeat - Feb 03, 2026

FDA Grants Priority Review to Takeda's Drug for Narcolepsy, Boos - GuruFocus

GuruFocus - Feb 10, 2026

Takeda Pharmaceutical Co Ltd (TSE:4502) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Yahoo Finance - Oct 29, 2025

Investors Can Find Comfort In Takeda Pharmaceutical's (TSE:4502) Earnings Quality - simplywall.st

simplywall.st - Feb 08, 2026

Innovent rings up $11.4B deal with Takeda for three I-O/ADC assets - bioworld.com

bioworld.com - Oct 22, 2025

Takeda: Lack Of Realistic Upside In Japanese Pharma (NYSE:TAK) - Seeking Alpha

Seeking Alpha - Dec 11, 2025

Takeda Can't Ax Most Of Heartburn Drug Pay-For-Delay Suit - Law360

Law360 - Feb 07, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment